Back

Prognosis of left ventricular dilatation in HFmrEF

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Progress in HFmrEF and HFpEF Heart Failure with Mid-Range Ejection Fraction (HFmrEF) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Henning Johann Steffen

University Medical Centre of Mannheim, Mannheim (Germany)

8 More presentations in this session

Presentation thumbnail
Worsening heart failure after primary catheter ablation in patients with atrial fibrillation with preserved ejection fraction: predictive value of HFA-PEFF score and H2FPEF score
Doctor S. Hirayama (Niigata, JP)
Abstract Slides Video
Presentation thumbnail
Absence of causal association between NAFLD and heart failure: mendelian randomization evidence"
Mr S. Huang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Quality of life and symptom burden among patients with heart failure with preserved ejection fraction (HFpEF): variations by BMI categories
Mr N. Upadhyay (Indianapolis, US) Doctor A. Plat (NL)
Abstract Slides Video
Presentation thumbnail
Diastolic dysfunction as a predictor of postoperative heart failure in non-cardiac surgery
Doctor S. Gefen (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Prognostic implications of multimorbidity in patients with heart failure with mildly reduced ejection fraction
Doctor T. Schupp (Mannheim, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Progress in HFmrEF and HFpEF

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Predictors of early left ventricular reverse remodelling and prognosis in new-onset heart failure of non-ischemic origin
thumbnail
Congress Presentation
Etiologies and predictors of mortality in an all-comer population of patients with non-ischemic heart failure
thumbnail
Congress Presentation
Propensity score-matched analysis in isolated left ventricular dilation and non-ischaemic dilated cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources